Lisa Shipley PhD

Dr Shipley is VP of Digital and Analytics Technologies in Merck Research Laboratories. She has the overall responsibility to design, operationalize, and direct Discovery, Preclinical and Early Development’s contribution to Merck’s digital vision. In partnership with key technical lines, she is responsible for the leadership, operational and strategic management of initiatives focused on advancing knowledge, experience and capabilities in digital technologies, data management and analysis to transform the use of digital health approaches in all stages of drug discovery and clinical trial management, moving from a site-centric to patient centric model of drug development.

Dr Shipley joined Merck in 2008 as the VP of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism before moving into her current role. Prior to joining Merck, Dr Shipley spent over 20 years at Eli Lilly in roles of increasing responsibility including the positions of executive director, Lean Six Sigma and vice president Drug Disposition, PK/PD and Trial Simulations. Dr Shipley obtained her undergraduate degree from McDaniel College and her doctoral degree in Pharmacology and Toxicology from the University of Maryland at Baltimore. Her postdoctoral training was conducted at the Walter Reed Army Institute of Research as a National Research Council Fellow elucidating the metabolism and pharmaco-kinetics of antileishmanial and antimalarial drugs under development by the US Army.